AU7440196A - Baboon mage-3 homologs, dna encoding the homologs, and a process for their use - Google Patents

Baboon mage-3 homologs, dna encoding the homologs, and a process for their use

Info

Publication number
AU7440196A
AU7440196A AU74401/96A AU7440196A AU7440196A AU 7440196 A AU7440196 A AU 7440196A AU 74401/96 A AU74401/96 A AU 74401/96A AU 7440196 A AU7440196 A AU 7440196A AU 7440196 A AU7440196 A AU 7440196A
Authority
AU
Australia
Prior art keywords
homologs
baboon
mage
dna encoding
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74401/96A
Inventor
Robert O Ralston
David B. Ring
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of AU7440196A publication Critical patent/AU7440196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
AU74401/96A 1995-10-12 1996-10-10 Baboon mage-3 homologs, dna encoding the homologs, and a process for their use Abandoned AU7440196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US511795P 1995-10-12 1995-10-12
US005117 1995-10-12
PCT/US1996/016319 WO1997013858A2 (en) 1995-10-12 1996-10-10 Baboon mage-3 homologs, dna encoding the homologs, and a process for their use

Publications (1)

Publication Number Publication Date
AU7440196A true AU7440196A (en) 1997-04-30

Family

ID=21714271

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74401/96A Abandoned AU7440196A (en) 1995-10-12 1996-10-10 Baboon mage-3 homologs, dna encoding the homologs, and a process for their use

Country Status (2)

Country Link
AU (1) AU7440196A (en)
WO (1) WO1997013858A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686068A (en) * 1994-03-24 1997-11-11 Ludwig Institute For Cancer Research Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof
AU742753C (en) * 1997-04-11 2002-12-05 Peter Kufer Primers and methods for the detection of disseminated tumor cells
US5965535A (en) 1997-09-12 1999-10-12 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
EP1659179B1 (en) 1998-02-05 2011-06-15 GlaxoSmithKline Biologicals s.a. Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
JP2003517310A (en) * 1999-12-10 2003-05-27 エピミューン， インコーポレイテッド Induction of a cellular immune response against MAGE2 / 3 using peptide and nucleic acid compositions
US7049413B2 (en) 2001-05-18 2006-05-23 Ludwig Institute For Cancer Research MAGE-A3 peptides presented by HLA class II molecules
JP2012529283A (en) * 2009-06-09 2012-11-22 ヴァクソン バイオテック Identification, optimization and use of immunotherapy for shared HLA-B * 0702 epitopes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235525B1 (en) * 1991-05-23 2001-05-22 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof

Also Published As

Publication number Publication date
WO1997013858A2 (en) 1997-04-17
WO1997013858A3 (en) 1997-06-05

Similar Documents

Publication Publication Date Title
AU7489596A (en) Reinforced formed part, process for its production and its use
AU1238895A (en) The use of benzazoles as UV absorbers, new benzazoles and a process for their preparation
AU4826196A (en) Cyclic compounds, their production and use
HUP9900339A3 (en) Water-soluble copolymers, process for producing the same and their use
AU6194094A (en) Sweetener, process for the preparation thereof and the use thereof
ZA964710B (en) Novel compounds, the preparation and use thereof.
HUP9602745A3 (en) Anticelladhesive piperidine- und pyrrolidine-carbonacids, pharm
AU3244797A (en) Indanylidene compounds, a process for their preparation and their use as UV absorbers
AU6845994A (en) Solid protector against uv, process for its preparation and use thereof
AU5467698A (en) Inorganic pigment granules, process for their production and their use
AU7227394A (en) Method for surface treatment, means for carrying out the method and the use thereof
AU8036598A (en) Titanium oxide-based photocatalyst, process for preparing the same, and use thereof
AU6550894A (en) Human serotonin receptors, dna encoding the receptors, and uses thereof
AU4388696A (en) Biocidal alcohols, their production and their use
AU3326297A (en) A process for producing inorganic granules and the use thereof
AU5123996A (en) Bactericidal mat, process for producing the same, and use thereof
AU6983494A (en) Indazolesulfonylurea derivative, use thereof, and intermediate for production thereof
AU1140197A (en) Pyridyl carbamates, process and intermediates for the preparation and use thereof
WO1997012963A3 (en) A paf-acetylhydrolase and use in therapy
EP0622369A3 (en) 2-Amino-4-quinoline-dihydropyridine, process for preparation and use thereof.
AU7440196A (en) Baboon mage-3 homologs, dna encoding the homologs, and a process for their use
AU4675596A (en) Azole compounds, their production and use
AU6609298A (en) Dual tube system, method and tools for the production thereof
AU7570296A (en) 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols
AU5895996A (en) Basic cobalt(II) carbonates, process for the production thereof and the use thereof